Get the latest tech news
Level Zero Health banks $6.9M to prove wearable medtech can take the strain out of hormone testing
Level Zero Health, a female-founded medical device startup that's aiming to break new ground by developing a device for continuous hormone monitoring, has
This is why the team is also working on a stepping stone single-use product (pictured above in prototype form), which they hope to get cleared for prescription use next year — to support intermittent hormone testing associated with medical use cases such as fertility (IVF) and low testosterone (TRT). The prototype wearable is able to take measurements throughout the day when worn — extracting a series of data points with the goal of “delivering value immediately” for use-cases such as IVF, where a woman might otherwise need to have multiple blood draws to monitor hormone levels. Rustamova says the team hopes to have concluded clinical trials and secured clearance for this single-use intermittent monitoring patch next year — with eyes on obtaining approval both from the U.S. regulator, the FDA, and a CE marking to allow them to sell into European healthcare markets (she says they’re not sure which may come first).
Or read this on TechCrunch
